Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 3
| |||||||
Eton Pharmaceuticals, Inc.
| 10K |
$2.10 | $21,042.00 | +0.97% | 1.04M |
Sep 22
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 12
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 7
| |||||||
Eton Pharmaceuticals, Inc.
| 10K |
$4.32 | $43,200.00 | +0.98% | 1.03M |
Aug 20
| |||||||
Eton Pharmaceuticals, Inc.
| 5K |
$5.96 | $29,800.00 | +0.49% | 1.03M |
Jun 3
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 3
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 12
| |||||||
Eton Pharmaceuticals, Inc.
| 5K |
$6.15 | $30,750.00 | +0.49% | 1.02M |
Aug 13
| |||||||
Eton Pharmaceuticals, Inc.
| 10K |
$7.93 | $79,325.86 | +0.99% | 1.02M |
May 20 - May 21
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 20
| |||||||
Eton Pharmaceuticals, Inc.
| 34.94K |
$6.00 | $60,000.00 | +3.49% | 1.03M |
Nov 15
| |||||||
Eton Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sagent Pharmaceuticals, Inc.
| -9.84K |
$21.75 | -$214,107.00 | -100.00% |
0
| +1 |
Aug 29
| ||||||
Sagent Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Sagent Pharmaceuticals, Inc.
| 9.84K |
—
|
—
|
∞
| 9.84K | +1 |
Apr 4
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||